Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.
about
Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responsesHost cytokine responses induced after overnight stimulation with novel M. tuberculosis infection phase-dependent antigens show promise as diagnostic candidates for TB disease.Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic areaImmunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosisMemory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subsetUtility of host markers detected in Quantiferon supernatants for the diagnosis of tuberculosis in children in a high-burden setting.Impairment of IFN-gamma response to synthetic peptides of Mycobacterium tuberculosis in a 7-day whole blood assayHeterogeneity among Homologs of Cutinase-Like Protein Cut5 in Mycobacteria.A Mycobacterium tuberculosis Dormancy Antigen Differentiates Latently Infected Bacillus Calmette-Guérin-vaccinated Individuals.Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.Universal stress protein Rv2624c alters abundance of arginine and enhances intracellular survival by ATP binding in mycobacteria.Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition.Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.Antigens for CD4 and CD8 T cells in tuberculosis.Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection.Foxp3 expression and nitric oxide production in peripheral blood mononuclear cells of communicants with pulmonary tuberculosis.Two distinct conformational states of Mycobacterium tuberculosis virulent factor early secreted antigenic target 6 kDa are behind the discrepancy around its biological functions.Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection.
P2860
Q27303136-52B56269-C253-4C75-92CE-B0FE8EA4E7EFQ28534690-94BAC3E6-CD94-496E-876F-F402CC828332Q33905078-C627DB0C-17C1-4844-B657-1262E07637BDQ34302593-8FF27691-31D7-4303-904B-4270F5ADDBEDQ34306108-8BDABDE4-1495-4D39-BE67-B68FCF634E39Q34566079-FC2C9720-90DF-4814-BD30-2C70FFCD1AE2Q34731357-334DC356-063E-4A14-A2DC-7C8D491BBFCEQ34949342-F8267624-CA25-48BF-A0E4-3830118513EBQ35692697-8AD28E90-429E-4208-97BB-D5E4331F68FFQ36038593-92B22A64-AAC5-489E-B914-996DCD3FA04EQ36154683-8F034355-D40B-49E8-8B58-3C77459451F8Q37352781-E879DD26-9852-4E9C-9A60-AC1BC7ED1D9EQ37505396-A3FE3268-70F6-448E-96D7-F060A4D7CB27Q37679327-3CC53A7D-C85C-40BB-BACC-56DE58A64851Q38059150-ADB5D0B2-8B91-43EC-8D1D-DFA318CDC45FQ38213801-F4A22F92-1696-4840-AE59-2050D2A86E9BQ38221214-0287F248-8DAD-4C1E-B09B-FF7ED91022CEQ38854712-323F6109-1BC5-47D5-A976-BDDCC84CDE80Q38880052-607669D3-74A8-4473-9B36-D7EDBBA2A6A5Q43537065-1A334CF0-91EF-4A4C-A6D9-1A975912475AQ46185300-ECCAADDD-4BE0-4DD4-9C3E-B6F354431FA1Q47223863-3C590DF9-F83F-407E-8FC1-475C3AC46C94Q49513549-74117476-229A-4AC8-891E-A2B220203966Q52655450-5664DC46-9207-4D22-93A0-5D7DBECCD154
P2860
Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Potential of novel Mycobacteri ...... ease in a high burden setting.
@ast
Potential of novel Mycobacteri ...... ease in a high burden setting.
@en
Potential of novel Mycobacteri ...... ease in a high burden setting.
@nl
type
label
Potential of novel Mycobacteri ...... ease in a high burden setting.
@ast
Potential of novel Mycobacteri ...... ease in a high burden setting.
@en
Potential of novel Mycobacteri ...... ease in a high burden setting.
@nl
prefLabel
Potential of novel Mycobacteri ...... ease in a high burden setting.
@ast
Potential of novel Mycobacteri ...... ease in a high burden setting.
@en
Potential of novel Mycobacteri ...... ease in a high burden setting.
@nl
P2093
P2860
P50
P356
P1476
Potential of novel Mycobacteri ...... ease in a high burden setting.
@en
P2093
Annemieke H Friggen
Gillian F Black
Kees L Franken
Kim Stanley
Michel R Klein
Paulin N Essone
T Mark Doherty
Tom H Ottenhoff
P2860
P2888
P356
10.1186/1471-2334-12-10
P577
2012-01-20T00:00:00Z
P5875
P6179
1001044759